0.43
-0.0816(-15.84%)
Currency In USD
| Previous Close | 0.52 |
| Open | 0.5 |
| Day High | 0.51 |
| Day Low | 0.42 |
| 52-Week High | 2.83 |
| 52-Week Low | 0.22 |
| Volume | 5.55M |
| Average Volume | 7.12M |
| Market Cap | 18.01M |
| PE | -0.21 |
| EPS | -2.07 |
| Moving Average 50 Days | 0.38 |
| Moving Average 200 Days | 0.43 |
| Change | -0.08 |
If you invested $1000 in ProPhase Labs, Inc. (PRPH) 10 years ago, it would be worth $252.03 as of September 13, 2025 at a share price of $0.434. Whereas If you bought $1000 worth of ProPhase Labs, Inc. (PRPH) shares 5 years ago, it would be worth $328.41 as of September 13, 2025 at a share price of $0.434.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
ProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products compa
ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025
GlobeNewswire Inc.
Sep 03, 2025 12:00 PM GMT
Company cancels the Equity Line of Credit (ELOC) UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
GlobeNewswire Inc.
Aug 19, 2025 12:00 PM GMT
UNIONDALE, NY, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced that it filed a definitive proxy statement (“DEF 1